The classroom microbiome and asthma morbidity in children attending 3 inner-city schools - 06/06/18
Doi : 10.1016/j.jaci.2018.02.022
Peggy S. Lai, MD, MPH a, b, c, Raivo Kolde, PhD a, Eric A. Franzosa, PhD b, Jonathan M. Gaffin, MD, MMSc c, d, Sachin N. Baxi, MD c, d, William J. Sheehan, MD c, d, Diane R. Gold, MD, MPH b, c, e, Dirk Gevers, PhD f, Ramnik J. Xavier, MD a, c, f, Wanda Phipatanakul, MD, MS c, f 
a Massachusetts General Hospital, Boston, Mass
b Harvard T.H. Chan School of Public Health, Boston, Mass
c Harvard Medical School, Boston, Mass
d Boston Children's Hospital, Boston, Mass
e Brigham and Women's Hospital, Boston, Mass
f Broad Institute of MIT and Harvard University, Cambridge, Mass
| This work was supported by a Boston Children's Hospital-Broad Institute Collaboration grant, as well as in part by the National Institutes of Health (grant nos. R01 AI 073964, U01 AI 110397, K24 AI 106822, and U01 AI 126614 to W.P.; grant no. K23 ES023700 to P.S.L.; grant no. P30 ES000002 to D. Dockery). This work was also supported by the American College of Allergy, Asthma, and Immunology Young Faculty Award. This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic health care centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health. Coway, Inc, graciously donated air cleaners and provided support in building the sham cleaners. The funding sources did not contribute to study design; collection, analysis, and interpretation of data; writing of the report; or the decision to submit the article for publication. |
|
| Disclosure of potential conflict of interest: P. S. Lai, E. A. Franzosa, J. M. Gaffin, and D. R. Gold report grants from the National Institutes of Health (NIH). R. Kolde reports personal fees from Koninklijke Philips N.V. W. Phipatanakul reports grants from the NIH and Genentech and support from Regeneron, Glaxo Smith Kline, Sanofi, Novartis, and Teva. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 141 - N° 6
P. 2311-2313 - juin 2018 Retour au numéro
Article précédent
- CD40LG duplication-associated autoimmune disease is silenced by nonrandom X-chromosome inactivation
- Carole Le Coz, Melissa Trofa, Camille M. Syrett, Anna Martin, Harumi Jyonouchi, Soma Jyonouchi, Montserrat C. Anguera, Neil Romberg
- Basophil Fc?RI expression is linked to time to omalizumab response in chronic spontaneous urticaria
- Gustavo Deza, Marta Bertolín-Colilla, Silvia Sánchez, Dulce Soto, Ramon M. Pujol, Ramon Gimeno, Ana M. Giménez-Arnau
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?